68Ga-DOTATATE与18F-FDG PET在EBV阳性非角化性鼻咽癌中的头对头比较
该研究对比68Ga-DOTATATE与18F-FDG PET/CT在EBV阳性非角化性鼻咽癌中的应用价值,26例原发肿瘤中18F-FDG的SUVmax中位数为15.00、68Ga-DOTATATE为9.73(P=0.001)。68Ga-DOTATATE在检出颅内及颅底侵犯方面优于18F-FDG,并检出更多远处转移(89/92 vs 54/92,P<0.001)。
要点
- 26例原发肿瘤中18F-FDG SUVmax中位数15.00 vs 68Ga-DOTATATE 9.73(P=0.001)。
- 68Ga-DOTATATE检出远处转移89/92(96.7%)vs 18F-FDG 54/92(58.7%),P<0.001。
- 以35% SUVmax为阈值的68Ga-DOTATATE肿瘤体积与增强MRI一致性最高。
核心结论
- 68Ga-DOTATATE PET/CT是检测EBV阳性非角化性鼻咽癌原发灶及转移灶、勾画原发肿瘤边界的 promising 影像方法。
研究设计与样本
- 患者接受18F-FDG与68Ga-DOTATATE PET扫描,比较病灶数目、示踪剂参数及由增强MRI、18F-FDG和68Ga-DOTATATE PET获得的原发肿瘤体积。
- 分析临床特征与PET参数的相关性及PET参数的预测价值。
主要发现
- 全部26例原发肿瘤中18F-FDG与68Ga-DOTATATE的SUVmax中位数分别为15.00和9.73(P=0.001)。
- 68Ga-DOTATATE PET在检测颅内及颅底侵犯方面优于18F-FDG PET。
- 以35% SUVmax为阈值的68Ga-DOTATATE原发肿瘤体积与增强MRI一致性最高。
- 68Ga-DOTATATE与18F-FDG PET/CT分别检出区域淋巴结转移103/108(95.4%)和101/108(93.5%)(P=0.552),SUVmax中位数分别为6.05和10.81(P<0.001)。
- 68Ga-DOTATATE PET/CT检出远处转移89/92(96.7%)vs 18F-FDG 54/92(58.7%)(P<0.001)。
关键数值与推荐
- 原发肿瘤SUVmax中位数:18F-FDG 15.00 vs 68Ga-DOTATATE 9.73(P=0.001)。
- 区域淋巴结转移检出:68Ga-DOTATATE 103/108(95.4%)vs 18F-FDG 101/108(93.5%)(P=0.552);SUVmax中位数6.05 vs 10.81(P<0.001)。
- 远处转移检出:68Ga-DOTATATE 89/92(96.7%)vs 18F-FDG 54/92(58.7%)(P<0.001)。
- 非客观缓解率组PET参数高于客观缓解率组(所有P值>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to compare the clinical application value of 68 Ga-DOTATATE and 18 F-FDG PET/CT in Epstein-Barr virus (EBV)-positive nonkeratinizing nasopharyngeal carcinoma. PATIENTS AND METHODS: Patients underwent 18 F-FDG and 68 Ga-DOTATATE PET scans. The lesion numbers, tracer parameters, and primary tumor volume derived from contrast-enhanced MRI, 18 F-FDG, and 68 Ga-DOTATATE PET were compared. The correlation between clinical characteristics and PET parameters as well as the predictive value of PET parameters were analyzed. RESULTS: The median maximum standard uptake values (SUV max ) of 18 F-FDG and 68 Ga-DOTATATE in all 26 primary tumors was 15.00 and 9.73, respectively ( P = 0.001). 68 Ga-DOTATATE PET was superior to 18 F-FDG PET in detecting intracranial and skull base involvement. The primary tumor volume of 68 Ga-DOTATATE with 35% SUV max as the threshold had the highest consistency with that of contrast-enhanced MRI. 68 Ga-DOTATATE and 18 F-FDG PET/CT detected 103/108 (95.4%) and 101/108 (93.5%) regional lymph nodes metastases ( P = 0.552), and the median SUV max was 6.05 and 10.81, respectively ( P < 0.001). Furthermore, 68 Ga-DOTATATE PET/CT detected more distant metastases than 18 F-FDG (89/92 [96.7%] vs 54/92 [58.7%], respectively, P < 0.001). The plasma EBV DNA was positively correlated with the total metabolic tumor volume, lesion glycolysis, somatostatin receptor-expressing tumor volume, and lesion somatostatin receptor expression (all P values <0.05). The PET parameters in the non-objective response rate group were higher than those in the objective response rate group (all P values >0.05). CONCLUSIONS: 68 Ga-DOTATATE PET/CT is a promising imaging modality for detecting primary and metastatic EBV-positive nonkeratinizing nasopharyngeal carcinoma and delineating primary tumor boundary.
引用
- Qi M, Zhou P, Huang S, et al. Head-to-Head Comparison of 68 Ga-DOTATATE and 18 F-FDG PET in EBV-Positive Nonkeratinizing Nasopharyngeal Carcinoma. Clin Nucl Med. 2024. PMID: 39668493. doi:10.1097/RLU.0000000000005623
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。